Serum Institute files Rs 100-crore case after a man claims illness
New Delhi : The Serum Institute, which is developing a coronavirus vaccine, has prepared a Rs 100-crore defamation lawsuit against a man who claimed a "virtual neurological breakdown" after being administered a dose of Covishield coronavirus vaccine.
NDTV quoted Serum Institute as saying, "The allegations in the notice are malicious and misconceived. While the Serum Institute of India is sympathetic to the volunteer's medical condition, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer. The volunteer is falsely laying the blame for his medical problems on the COVID vaccine trial."
"The claim is malicious because the volunteer was specifically informed by the medical team that the complications he suffered were independent of the vaccine trial he underwent. In spite of specifically being made aware of the same, he still chose to go public and malign the reputation of the company," the statement added.
The Serum Institute has said that they will file a lawsuit against the person of Rs 100 crores and will continue to defend itself from such malicious claims.
Earlier, a Chennai based man was administered Covid vaccine during the third phase trials under Serum Institute. He claimed Rs 5 crores as compensation for "a serious adverse event after being administered the under-trial vaccine".
He was administered the dose at Chennai's Sri Ramachandra Institute of Higher Education and Research (SRIHER) on October 1.
According to his legal notice, which was filed November 21, ten days later he began experiencing "severe headaches", "total behavioural change" and "irritation towards light and sound". Subsequently, the notice claims, he could not recognise or speak to anyone.
Meanwhile, Serum Institute has rejected such claims and said that the vaccine has already been tested in UK on the age group of 18-55 years and it is safe with no such major side-effects.
The Drugs Controller General of India (DCGI) and an ethics committee at the Sri Ramachandra Institute will investigate the man's claim, a report by news agency PTI said.